Yes. GLP-1+GIP agonists are FDA-approved and have a well-established safety profile. At Yuomo, all injections are prescribed and supervised by a qualified medical team, with weekly monitoring to ensure your response is on track.

Individuals with a history of pancreatitis, severe GI disease, medullary thyroid carcinoma (MTC), or those on conflicting medications may not qualify. Eligibility is confirmed only after a doctor consultation and review of your medical history.

No. Our team will give inject you in-clinic. If you prefer doing it at home, our team provides with hands-on training so you can administer the injection confidently and painlessly at home. You are supported throughout with weekly check-ins.

Most patients notice changes within 1-2 weeks. You start losing 0.8-1Kg weight every week. Fat percentage continues to drop progressively with adherence to the protocol. Consistent results are typically achieved over 12–24 weeks depending on your starting point.

Our program is designed for a healthy fat loss of 10–15 kg over 3–4 months, varying by individual. Results depend on adherence to the diet plan, activity level, and medical factors.

No. Our protocol is specifically designed to preserve lean muscle while targeting fat. The combination of a high-protein diet plan, personalised supplementation, in-clinic therapy sessions for muscle preservation and skin tightening, and resistance training guidance ensures your muscle is protected throughout.

Resistance training is strongly recommended and will significantly accelerate your results.

Every patient on the GLP-1+GIP program has a mandatory weekly physical check-in at the clinic. This includes weight and body composition tracking, side effect review, injection technique assessment, and diet plan adjustments as needed. These sessions ensure your program stays on track and your safety is monitored throughout.

The program is generally well tolerated. Common, temporary effects include mild nausea, decreased appetite, and occasional constipation — especially in the first few weeks as your body adjusts. In rare cases, more serious effects such as pancreatitis have been reported. Your care team monitors your progress closely to minimise risks and respond quickly if needed.

Yes. Baseline blood work is part of your onboarding, and periodic testing is done during the program to track metabolic markers and ensure safety. This is included as part of your care plan.